951 related articles for article (PubMed ID: 17174513)
41. Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer.
Pugliese MS; Karam AK; Hsu M; Stempel MM; Patil SM; Ho AY; Traina TA; Van Zee KJ; Cody HS; Morrow M; Gemignani ML
Ann Surg Oncol; 2010 Apr; 17(4):1063-8. PubMed ID: 20033325
[TBL] [Abstract][Full Text] [Related]
42. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy.
Alran S; De Rycke Y; Fourchotte V; Charitansky H; Laki F; Falcou MC; Benamor M; Freneaux P; Salmon RJ; ; Sigal-Zafrani B
Ann Surg Oncol; 2007 Aug; 14(8):2195-201. PubMed ID: 17294071
[TBL] [Abstract][Full Text] [Related]
43. The reliability and accuracy of intraoperative imprint cytology of sentinel lymph nodes in breast cancer.
Pogacnik A; Klopcic U; Grazio-Frković S; Zgajnar J; Hocevar M; Vidergar-Kralj B
Cytopathology; 2005 Apr; 16(2):71-6. PubMed ID: 15787648
[TBL] [Abstract][Full Text] [Related]
44. Use of intraoperative stereomicroscopy for preventing loss of metastases during frozen sectioning of sentinel lymph nodes in breast cancer.
Varga Z; Rageth C; Saurenmann E; Honegger C; von Orelli S; Fehr M; Fink D; Seifert B; Moch H; Caduff R
Histopathology; 2008 Apr; 52(5):597-604. PubMed ID: 18370956
[TBL] [Abstract][Full Text] [Related]
45. Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy.
King TA; Ganaraj A; Fey JV; Tan LK; Hudis C; Norton L; Cody HS; Borgen PI
Cancer; 2004 Sep; 101(5):926-33. PubMed ID: 15329899
[TBL] [Abstract][Full Text] [Related]
46. [Sentinel lymph node biopsy with micrometastases in breast cancer: histological data and surgical implications. About a series of 201 axillary dissections after peroperative sentinel node identification].
Marin C; Mathelin C; Neuville A; Mertz L; Constantinesco A; Chenard MP; Bellocq JP
Bull Cancer; 2003 May; 90(5):459-65. PubMed ID: 12850769
[TBL] [Abstract][Full Text] [Related]
47. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
[TBL] [Abstract][Full Text] [Related]
48. Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer.
Noguchi M
Eur J Surg Oncol; 2008 Feb; 34(2):129-34. PubMed ID: 17498911
[TBL] [Abstract][Full Text] [Related]
49. Histopathologic analysis of sentinel lymph nodes in breast carcinoma.
Hsieh PP; Ho WL; Yeh DC; Liu TJ; Wu CC; Lin JH; Wang SJ
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):744-50. PubMed ID: 11076431
[TBL] [Abstract][Full Text] [Related]
50. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
[TBL] [Abstract][Full Text] [Related]
51. Factors that predict the burden of axillary disease in breast cancer patients with a positive sentinel node.
Beriwal S; Soran A; Kocer B; Wilson JW; Ahrendt GM; Johnson R
Am J Clin Oncol; 2008 Feb; 31(1):34-8. PubMed ID: 18376225
[TBL] [Abstract][Full Text] [Related]
52. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community.
Davit FE; Gatmaitan P; Garguilo G
Am Surg; 2008 May; 74(5):423-7. PubMed ID: 18481500
[TBL] [Abstract][Full Text] [Related]
53. Intraoperative cytologic examination of breast sentinel lymph nodes: test utility and patient impact.
Dabbs DJ; Fung M; Johnson R
Breast J; 2004; 10(3):190-4. PubMed ID: 15125743
[TBL] [Abstract][Full Text] [Related]
54. Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis.
Jinno H; Sakata M; Asaga S; Wada M; Shimada T; Kitagawa Y; Suzuki T; Nakahara T; Kitamura N; Kubo A; Mukai M; Ikeda T; Kitajima M
Breast J; 2008; 14(6):551-5. PubMed ID: 19000054
[TBL] [Abstract][Full Text] [Related]
55. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
56. Sentinel Node Biopsy Examination for Breast Cancer in a Routine Laboratory Practice: Results of a Pilot Study.
Khoo JJ; Ng CS; Sabaratnam S; Arulanantham S
Asian Pac J Cancer Prev; 2016; 17(3):1149-55. PubMed ID: 27039740
[TBL] [Abstract][Full Text] [Related]
57. Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?
Port ER; Patil S; Stempel M; Morrow M; Cody HS
Cancer; 2010 Apr; 116(8):1987-91. PubMed ID: 20151427
[TBL] [Abstract][Full Text] [Related]
58. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
59. Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes.
Noguchi M
Br J Surg; 2002 Dec; 89(12):1505-15. PubMed ID: 12445058
[TBL] [Abstract][Full Text] [Related]
60. A simple nomogram to evaluate the risk of nonsentinel node metastases in breast cancer patients with minimal sentinel node involvement.
Meretoja TJ; Strien L; Heikkilä PS; Leidenius MH
Ann Surg Oncol; 2012 Feb; 19(2):567-76. PubMed ID: 21792511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]